Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Phase 2
30
about 1.6 years
18–99
1 site in GA
What this study is about
Researchers are testing if semaglutide, a medication used to treat alcohol use disorder (AUD), can help reduce alcohol consumption in people with HIV and AUD. The trial will last about 592 days and involve approximately 30 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take semaglutide
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
semaglutide (GLP-1 agonist; stimulates insulin release)
oral (Oral Tablet)
Primary: Safety of study assessed by adverse event reporting
Psychiatry / Mental Health, Immune, Infectious